The 4 patients with esophageal or head/neck squamous cell carcinoma who exhibited an immune response to MAGE-A4 survived for a median of 3.3 months (range, 2.5 to 10.9). The gene discussed is MAGEA4; the disease is head and neck squamous cell carcinoma.